Benefits and risks of testosterone treatment for hypoactive sexual desire disorder in women: a critical review of studies published in the decades preceding and succeeding the advent of phosphodiesterase type 5 inhibitors. (2014). Clinics, 69(4), 294-303. https://doi.org/10.1590/clin.v69i4.79512